AQUESTIVE THERAPEUTICS INC. - COMMON STOCK

Aquestive Therapeutics to Announce Fourth Quarter and Year End 2020 Financial Results and Recent Business Highlights on March 9 and Host Conference Call on March 10 at 8:00 a.m. ET

17 فبراير 2021 06:30:00 بحسب Nasdaq GlobeNewswire

Aquestive Therapeutics Strengthens Board of Directors with Appointments of Julie Krop, M.D., and Marco Taglietti, M.D., and Announces Resignation of Douglas K. Bratton from Board of Directors

09 فبراير 2021 06:30:00 بحسب Nasdaq GlobeNewswire

Aquestive Therapeutics Appoints Mark Lepore, MD, as Chief Medical Officer for Allergy

28 يناير 2021 06:30:00 بحسب Nasdaq GlobeNewswire

Aquestive Therapeutics Provides Business Update

07 يناير 2021 06:30:00 بحسب Nasdaq GlobeNewswire

Aquestive Therapeutics to Present at Two Upcoming Investor Conferences

04 يناير 2021 06:30:00 بحسب Nasdaq GlobeNewswire